TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31914940

Group type: EXPERIMENTAL
Intervention: Rifampin, 600 mg daily for 6 weeks
Number of subjects: 880

Group type: COMPARATOR
Intervention: Matched placebo (riboflavin)
Number of subjects: 880
Study: 30935657

Group type: EXPERIMENTAL
Intervention: Ocriplasmin (0.125 mg intravitreal injection)
Number of subjects: 480
Study: 28881220

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily life EF behavior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure-based CBT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26366278

Group type: EXPERIMENTAL
Intervention: Mitomycin C 0.1% injected submucosally after IOU
Number of subjects: 151

Group type: COMPARATOR
Intervention: IOU only (Control)
Number of subjects: 151
Study: 26255546

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (200 mg/d)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 22987921

Group type: EXPERIMENTAL
Intervention: Birth weight
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Current pulse pressure
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Physical activity level
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Current weight
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Normal relative wall thickness and increased left ventricular mass index (eccentric remodeling)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Increase in both normal relative wall thickness and left ventricular mass index (concentric, increased LVM)
Number of subjects: 418
Study: 19372453

Group type: EXPERIMENTAL
Intervention: B-vitamins
Number of subjects: 505

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 505
Study: 17321928

Group type: EXPERIMENTAL
Intervention: Ketamine 0.15 mg/kg IV
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 360
Study: 15138439

Group type: EXPERIMENTAL
Intervention: Methamphetamine (0.15 mg/kg)
Number of subjects: 7
Study: 11438499

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9146783

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Tauro-ursodeoxycholic acid
Number of subjects: 23
Study: 7525515

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (40-50 Gy)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No radiotherapy (Control)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 88
Study: 2438923

Group type: EXPERIMENTAL
Intervention: Pirmenol hydrochloride (200 to 400 mg daily)
Number of subjects: 196
Study: 31843426

Group type: COMPARATOR
Intervention: Sham positive airway pressure (4 cmH2O)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Incentive spirometry, airway clearance, mobilisation, and sham positive pressure (4 cmH2O)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Incentive spirometry, airway clearance, mobilisation, and positive airway pressure (15 cmH2O)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group with sham positive airway pressure (4 cmH2O)
Number of subjects: 156
Study: 30767298

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 271
Study: 28539539

Group type: EXPERIMENTAL
Intervention: Bococizumab 50 mg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Bococizumab 100 mg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Bococizumab 150 mg
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg daily
Number of subjects: 218
Study: 24911019

Group type: EXPERIMENTAL
Intervention: Factors associated with low PA in men: age, being divorced or separated, still working, having a weak social network, poor diet, and a health professional's suggestion to increase PA.
Number of subjects: 1303

Group type: EXPERIMENTAL
Intervention: Factors associated with low PA in women: cardiovascular disease and depressive symptoms.
Number of subjects: 1303
Study: 23438223

Group type: EXPERIMENTAL
Intervention: 10% maltodextrin (CHO) mouth rinse
Number of subjects: 12

Group type: COMPARATOR
Intervention: Taste-matched placebo (PLB) solution
Number of subjects: 12
Study: 22097205

Group type: EXPERIMENTAL
Intervention: Education about clinical research
Number of subjects: 258

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 258
Study: 19188925

Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin (5 pmol kg(‐1) min(‐1))
Number of subjects: 26
Study: 16507585

Group type: EXPERIMENTAL
Intervention: Fontolizumab 4 mg/kg
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Fontolizumab 10 mg/kg
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 15640628

Group type: EXPERIMENTAL
Intervention: Afelimomab 1 mg/kg for 3 days
Number of subjects: 2634

Group type: COMPARATOR
Intervention: Placebo for 3 days
Number of subjects: 2634
Study: 11385886

Group type: EXPERIMENTAL
Intervention: St John's wort
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9282480

Group type: EXPERIMENTAL
Intervention: Pattern-reversal visual evoked potentials (PRVEP's) analysis using quadratic spline wavelet
Number of subjects: 0
Study: 8298071

Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride (12 mg dose) administered after a standardized meal
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fadrozole hydrochloride (12 mg dose) administered after fasting for 12 hours
Number of subjects: 9
Study: 3106096

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) 100 mg for 5 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Naloxone (2 mg intravenous bolus followed by 1.6 mg/hour for 9 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study: 2661789

Group type: EXPERIMENTAL
Intervention: MBDL regimen (metoclopramide 8 mg/kg, benztropine 0.04 mg/kg, dexamethasone 0.7 mg/kg, lorazepam 0.1 mg/kg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: MBDL regimen
Number of subjects: 26

Group type: COMPARATOR
Intervention: Chlorpromazine (3.3 mg/kg in four doses over 24 hours)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 26
Study: 31292845

Group type: EXPERIMENTAL
Intervention: Tongxiening Granules (TXNG) 5 g per time combined with pinaverium bromide Tablet simulator (50 mg per time), 3 times per day for 6 weeks
Number of subjects: 342

Group type: COMPARATOR
Intervention: TXNG simulator (5 g per time) combined with pinaverium bromide Tablets (50 mg per time), 3 times per day for 6 weeks
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 342
Study: 28898105

Group type: EXPERIMENTAL
Intervention: Knee flexion moment (KFM) before ACLR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Knee flexion angle (KFA) before ACLR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Knee flexion moment (KFM) at 6 months after ACLR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Knee flexion angle (KFA) at 6 months after ACLR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Vertical ground-reaction force (vGRF) at 6 months after ACLR
Number of subjects: 33
Study: 25070686

Group type: EXPERIMENTAL
Intervention: (177)Lu-EDTMP at a dose of 1,295 MBq (group A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: (177)Lu-EDTMP at a dose of 2,590 MBq (group B)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: (177)Lu-EDTMP
Number of subjects: 44
Study: 23534022

Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2 (SB)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Adper Easy One (EASY)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Adper SE Plus (SE)
Number of subjects: 36
Study: 21735721

Group type: COMPARATOR
Intervention: Dohsa + Attention (D + A) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dohsa (D) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 19529886

Group type: EXPERIMENTAL
Intervention: Catheter ablation for atrial fibrillation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Average strain
Number of subjects: 40
Study: 16924691

Group type: EXPERIMENTAL
Intervention: Farr method
Number of subjects: 550

Group type: COMPARATOR
Intervention: ELISA method
Number of subjects: 550
Study: 15453912

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 11349175

Group type: EXPERIMENTAL
Intervention: Spontaneous trial of labor
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Induced trial of labor
Number of subjects: 505

Group type: COMPARATOR
Intervention: Elective repeat cesarean
Number of subjects: 505
Study: 8996289

Group type: EXPERIMENTAL
Intervention: Ticlopidine (≥ 72 hours)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No ticlopidine or Ticlopidine (≤ 24 hours)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Ticlopidine (≤ 24 hours)
Number of subjects: 85
Study: 7984592

Group type: EXPERIMENTAL
Intervention: Detoxication therapy at the start of combined treatment
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Detoxication therapy
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Minor hemosorption
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: EI tests
Number of subjects: 191
Study: 3545130

Group type: EXPERIMENTAL
Intervention: Verapamil hydrochloride
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 29769834

Group type: EXPERIMENTAL
Intervention: 10°C continuous knee cooling for one hour
Number of subjects: 20

Group type: COMPARATOR
Intervention: 18°C continuous knee cooling for one hour
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups during maximal voluntary contraction (MVC)
Number of subjects: 20
Study: 26391583

Group type: EXPERIMENTAL
Intervention: Quality assessment (QA) group with Doppler ultrasound (DU) and ultrasound dilution method (UDM)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Quality assessment (QA) group
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 196
Study: 25186820

Group type: EXPERIMENTAL
Intervention: Sevoflurane for anaesthesia maintenance
Number of subjects: 200

Group type: COMPARATOR
Intervention: Propofol-based total intravenous anaesthesia
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 200

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 200
Study: 22344610

Group type: EXPERIMENTAL
Intervention: CarbCount
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: CarbCountABC
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control
Number of subjects: 51
Study: 20540447

Group type: EXPERIMENTAL
Intervention: Pressure-regulating ear plugs (PREP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No Pressure-regulating ear plugs (Control)
Number of subjects: 21
Study: 17151594

Group type: EXPERIMENTAL
Intervention: Probiotic containing milk drink
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 16379164

Group type: EXPERIMENTAL
Intervention: Participatory dental health education (DHE) programme
Number of subjects: 520

Group type: COMPARATOR
Intervention: National teaching DHE programme
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Net cavitated carious increment
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Health centre staff support
Number of subjects: 520
Study: 15384291

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 24

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 24
Study: 9974425

Group type: EXPERIMENTAL
Intervention: HRT (2 mg estradiol valerate from day 1 to 21 and 1 mg cyproterone acetate from day 12 to 21)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo (500 mg/d calcium lactate)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study: 7572684

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 447

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 447
Study: 2142575

Group type: EXPERIMENTAL
Intervention: 75 micrograms of gestodene + 30 micrograms of ethinyl estradiol
Number of subjects: 68

Group type: COMPARATOR
Intervention: 150 micrograms of desogestrel + 30 micrograms ethinyl estradiol
Number of subjects: 68
Study: 7023233

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 37

Group type: COMPARATOR
Intervention: Antihuman thymocyte globulin (ATG)
Number of subjects: 37
Study: 31867656

Group type: EXPERIMENTAL
Intervention: Red packaging
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Corrective messaging
Number of subjects: 426

Group type: COMPARATOR
Intervention: Advertisement content recall
Number of subjects: 426
Study: 30012387

Group type: EXPERIMENTAL
Intervention: Horticultural therapy program (twice/week for 12 sessions)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 26538372

Group type: EXPERIMENTAL
Intervention: Circumferential ablation
Number of subjects: 119

Group type: COMPARATOR
Intervention: Segmental ablation
Number of subjects: 119
Study: 24402595

Group type: EXPERIMENTAL
Intervention: Mesh Group (porcine small intestine submucosa mesh)
Number of subjects: 57

Group type: COMPARATOR
Intervention: No Mesh Group (native tissue repair)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Mesh Group
Number of subjects: 57

Group type: COMPARATOR
Intervention: No Mesh Group
Number of subjects: 57
Study: 22030724

Group type: EXPERIMENTAL
Intervention: Single injection (group S): 30 mL of mepivacaine 1.5%
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Double injection (group D): 15 mL of mepivacaine 1.5% at the junction of the subclavian artery and the first rib, followed by 15 mL at the lateral aspect of the brachial plexus
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Single injection (group S)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Double injection (group D)
Number of subjects: 102
Study: 19776178

Group type: EXPERIMENTAL
Intervention: S-(-)equol administered as SE5-OH tablets (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S-(-)equol administered as SE5-OH tablets (30 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S-(-)equol (both doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Equol-producer status
Number of subjects: 12
Study: 17053928

Group type: EXPERIMENTAL
Intervention: APAP with C-Flex
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard CPAP
Number of subjects: 15
Study: 15343013

Group type: EXPERIMENTAL
Intervention: NIPSV
Number of subjects: 46

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 46
Study: 11181984

Group type: EXPERIMENTAL
Intervention: Perindopril (ACE inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9440721

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2a maintenance, 3 million U three times weekly for 1 year
Number of subjects: 315

Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2a maintenance
Number of subjects: 315
Study: 7806024

Group type: EXPERIMENTAL
Intervention: Indian neonates
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Polynesian babies
Number of subjects: 123
Study: 2570732

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg b.i.d.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aspirin 900 mg b.i.d. for 48 h
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Famotidine 2 mg b.i.d.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 234130

Group type: EXPERIMENTAL
Intervention: Sodium fluoride dentifrice (0.1% F)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonfluoride dentifrice
Number of subjects: 100
Study: 31982328

Group type: EXPERIMENTAL
Intervention: PNEIMED training (30 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Academic lessons (30 hours)
Number of subjects: 40
Study: 31336766

Group type: EXPERIMENTAL
Intervention: Preservative-free latanoprost
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: BAC-preserved latanoprost
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Preservative-free tafluprost
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: BAC-preserved bimatoprost
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no topical antiglaucoma medications)
Number of subjects: 108
Study: 27070908

Group type: EXPERIMENTAL
Intervention: Real-time tissue elastography (RTE)
Number of subjects: 132
Study: 26501236

Group type: EXPERIMENTAL
Intervention: Local corticosteroid therapy
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroid therapy
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 182
Study: 23507836

Group type: EXPERIMENTAL
Intervention: Moderate‐intensity endurance‐type exercise
Number of subjects: 60
Study: 20958916

Group type: EXPERIMENTAL
Intervention: Laparoscopic devascularization starting at the ileocolic artery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open surgery (control group)
Number of subjects: 40
Study: 19513890

Group type: EXPERIMENTAL
Intervention: Accelerated care program (A group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional care program (C group)
Number of subjects: 40
Study: 16416222

Group type: EXPERIMENTAL
Intervention: 10 mg lafutidine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 mg famotidine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water only (control)
Number of subjects: 6
Study: 15603652

Group type: EXPERIMENTAL
Intervention: Absorbable polymer membrane (Seamguard, Gore) integrated into the gastric linear staple‐line (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional linear stapling system (group B)
Number of subjects: 20
Study: 11407964

Group type: EXPERIMENTAL
Intervention: Live music of simple guitar accompaniment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Live music of complex guitar accompaniment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Recorded music of simple guitar accompaniment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Recorded music of complex guitar accompaniment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All conditions (live and recorded music with simple and complex guitar accompaniment)
Number of subjects: 8
Study: 9164898

Group type: EXPERIMENTAL
Intervention: Intrinsic myocardial composition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Left ventricular mass
Number of subjects: 0
Study: 7780350

Group type: EXPERIMENTAL
Intervention: Single-lumen central venous catheters (Group I, 25 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Double-lumen central venous catheters (Group II, 25 patients)
Number of subjects: 50
Study: 2171617

Group type: EXPERIMENTAL
Intervention: Oral salbutamol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated matched controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ex vivo incubation with digoxin
Number of subjects: 0
Study: 377038

Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulphamethoxazole (TMP/SMX)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 56
Study: 31038418

Group type: EXPERIMENTAL
Intervention: Recreational music therapy (RMT)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Educational lyric analysis for illness management and recovery (ELA-IMR)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Educational songwriting for illness management and recovery (ESW-IMR)
Number of subjects: 113
Study: 31891605

Group type: EXPERIMENTAL
Intervention: D2/D3 receptor agonist pramipexole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 27819192

Group type: EXPERIMENTAL
Intervention: Elbow-toe bridge
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Side bridge
Number of subjects: 9
Study: 26655885

Group type: EXPERIMENTAL
Intervention: 7-W endovenous laser ablation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 15-W endovenous laser ablation
Number of subjects: 36
Study: 23721411

Group type: EXPERIMENTAL
Intervention: Single dose of gentamicin in combination with metronidazole
Number of subjects: 500

Group type: COMPARATOR
Intervention: Multiple doses of gentamicin in combination with metronidazole
Number of subjects: 500
Study: 21435220

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) treatment
Number of subjects: 22
Study: 18533896

Group type: EXPERIMENTAL
Intervention: GluF (glucose+fructose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Glu (glucose alone)
Number of subjects: 20
Study: 17926989

Group type: EXPERIMENTAL
Intervention: WF10 (0.5 mL/kg body weight/day for five consecutive days, repeated every 3 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (radiotherapy alone)
Number of subjects: 13
Study: 15528775

Group type: EXPERIMENTAL
Intervention: Academic detailing plus printed materials
Number of subjects: 31

Group type: COMPARATOR
Intervention: Printed materials only
Number of subjects: 31
Study: 11863318

Group type: EXPERIMENTAL
Intervention: Jet nebulizer with glass ampoule (group JG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Jet nebulizer with polycarbonate ampoule (group JP)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer (group US)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Jet nebulizers (group JG and JP)
Number of subjects: 27
Study: 8707752

Group type: EXPERIMENTAL
Intervention: 1000 mg valaciclovir
Number of subjects: 18

Group type: COMPARATOR
Intervention: 30 mL Maalox 65 min after valaciclovir
Number of subjects: 18

Group type: COMPARATOR
Intervention: 30 mL Maalox 30 min before valaciclovir
Number of subjects: 18
Study: 1602388

Group type: COMPARATOR
Intervention: i.v. cocaine hydrochloride (0, 16 and 32 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: smoked cocaine base (0, 25 and 50 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: smoked cocaine base (50 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: smoked cocaine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: i.v. cocaine
Number of subjects: 10